Review




Structured Review

STEMCELL Technologies Inc methocult gf h4434
DNA methylation changes during hematopoietic differentiation. ( A ) Matrix showing the number of demethylated CpG sites in each hematopoietic cell subset and demethylated CpG sites shared between distinct hematopoietic cell types. ( B ) Illumina array methylation clustering heatmap of SHEF-1 hESC line hypermethylated genes, demethylated in at least one of the six hematopoietic cell types analyzed: <t>CD34</t> + HSPCs, neutrophils, B cells, NK cells, CD8 + T cytotoxic cells (CD8 + ) and CD4 + T helper cells (CD4 + ). Methylation levels are indicated as in B. ( C ) Box plots of microarray-based gene expression data (log scale). In each blood cell type, specific demethylated genes exhibited higher expression levels compared to other cell types. P -values are shown. n = number of genes analyzed.
Methocult Gf H4434, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd34++fraction/methocult/pmc03245917-227-1-36
Average 90 stars, based on 1 article reviews
methocult gf h4434 - by Bioz Stars, 2026-11
90/100 stars

Images

1) Product Images from "A promoter DNA demethylation landscape of human hematopoietic differentiation"

Article Title: A promoter DNA demethylation landscape of human hematopoietic differentiation

Journal: Nucleic Acids Research

doi: 10.1093/nar/gkr685

DNA methylation changes during hematopoietic differentiation. ( A ) Matrix showing the number of demethylated CpG sites in each hematopoietic cell subset and demethylated CpG sites shared between distinct hematopoietic cell types. ( B ) Illumina array methylation clustering heatmap of SHEF-1 hESC line hypermethylated genes, demethylated in at least one of the six hematopoietic cell types analyzed: CD34 + HSPCs, neutrophils, B cells, NK cells, CD8 + T cytotoxic cells (CD8 + ) and CD4 + T helper cells (CD4 + ). Methylation levels are indicated as in B. ( C ) Box plots of microarray-based gene expression data (log scale). In each blood cell type, specific demethylated genes exhibited higher expression levels compared to other cell types. P -values are shown. n = number of genes analyzed.
Figure Legend Snippet: DNA methylation changes during hematopoietic differentiation. ( A ) Matrix showing the number of demethylated CpG sites in each hematopoietic cell subset and demethylated CpG sites shared between distinct hematopoietic cell types. ( B ) Illumina array methylation clustering heatmap of SHEF-1 hESC line hypermethylated genes, demethylated in at least one of the six hematopoietic cell types analyzed: CD34 + HSPCs, neutrophils, B cells, NK cells, CD8 + T cytotoxic cells (CD8 + ) and CD4 + T helper cells (CD4 + ). Methylation levels are indicated as in B. ( C ) Box plots of microarray-based gene expression data (log scale). In each blood cell type, specific demethylated genes exhibited higher expression levels compared to other cell types. P -values are shown. n = number of genes analyzed.

Techniques Used: DNA Methylation Assay, Methylation, Microarray, Gene Expression, Expressing

Promoter methylation and expression levels of hematopoietic genes in CD34 + HSPCs, cells differentiated from CD34 + and iPSCs generated from CD34 + HSPCs. ( A ) High purity sorted CB-derived CD34 + HSPCs (top middle panel) were differentiated in vitro (Diff-CD34) for 14 days in the presence of SCF, GM-CSF, IL3 and EPO. Granulocyte (CFU-G), monocyte (CFU-M), granulo-monocyte (CFU-GM) and erythroid (BFU-E) colony forming units were scored by light microscopy (right panels). Additionally, CB-derived CD34 + HSPCs were induced to travel back in development by generating iPSCs through ectopic expression of Oct4, Klf4, Sox2 and c-Myc (left panel shows a phase contrast image of a CD34-iPSC). The bottom panel shows a scatter plot of remethylated genes in CD34-iPSC (red) ( Supplementary Table S13 ) and demethylated genes in the differentiated CD34 progeny (Diff–CD34) (green) ( Supplementary Table S12 ). ( B ) Promoter methylation and expression of HLA-DR, CD31 and PIK3CD. Methylation and expression for each gene is indicated as in . Expression by flow cytometry of each gene in CD34-iPSC (top panel) and CD34 + HSPCs (bottom panel). For PIK3CD, WB analysis was performed in CD34 + HSPCs, CD34-iPSC and Diff-CD34 (β-actin was used as loading control).
Figure Legend Snippet: Promoter methylation and expression levels of hematopoietic genes in CD34 + HSPCs, cells differentiated from CD34 + and iPSCs generated from CD34 + HSPCs. ( A ) High purity sorted CB-derived CD34 + HSPCs (top middle panel) were differentiated in vitro (Diff-CD34) for 14 days in the presence of SCF, GM-CSF, IL3 and EPO. Granulocyte (CFU-G), monocyte (CFU-M), granulo-monocyte (CFU-GM) and erythroid (BFU-E) colony forming units were scored by light microscopy (right panels). Additionally, CB-derived CD34 + HSPCs were induced to travel back in development by generating iPSCs through ectopic expression of Oct4, Klf4, Sox2 and c-Myc (left panel shows a phase contrast image of a CD34-iPSC). The bottom panel shows a scatter plot of remethylated genes in CD34-iPSC (red) ( Supplementary Table S13 ) and demethylated genes in the differentiated CD34 progeny (Diff–CD34) (green) ( Supplementary Table S12 ). ( B ) Promoter methylation and expression of HLA-DR, CD31 and PIK3CD. Methylation and expression for each gene is indicated as in . Expression by flow cytometry of each gene in CD34-iPSC (top panel) and CD34 + HSPCs (bottom panel). For PIK3CD, WB analysis was performed in CD34 + HSPCs, CD34-iPSC and Diff-CD34 (β-actin was used as loading control).

Techniques Used: Methylation, Expressing, Generated, Derivative Assay, In Vitro, Light Microscopy, Flow Cytometry, Control

Cartoon depicting the overall methylation levels of hematopoietic genes at different developmental/differentiation stages: hESC, CD34 + HSPCs and mature hematopoietic cell types (undifferentiated stages, purple nuclei; neutrophils, pink nucleus; lymphoid cells, blue nuclei). For each differentiation stage, the heatmap shows the methylation levels of a selected group of hypermethylated genes in hESCs that are demethylated in that cell type ( Supplementary Table S11 ). Names of some key blood genes are mapped at the right of each methylation heatmap.
Figure Legend Snippet: Cartoon depicting the overall methylation levels of hematopoietic genes at different developmental/differentiation stages: hESC, CD34 + HSPCs and mature hematopoietic cell types (undifferentiated stages, purple nuclei; neutrophils, pink nucleus; lymphoid cells, blue nuclei). For each differentiation stage, the heatmap shows the methylation levels of a selected group of hypermethylated genes in hESCs that are demethylated in that cell type ( Supplementary Table S11 ). Names of some key blood genes are mapped at the right of each methylation heatmap.

Techniques Used: Methylation

Related Articles

other:

Article Title: Differential expression of a disease-associated MRE11 variant reveals distinct phenotypic outcomes
Article Snippet: Cells were then diluted to a concentration of 2x10 5 cells/mL (BM) or 1x10 6 cells/mL (splenocytes) and plated in duplicate in complete MethoCult (M3434, StemCell Technologies) media according to manufacturer’s instructions.

Article Title: Martinostat as a novel HDAC inhibitor to overcome tyrosine kinase inhibitor resistance in chronic myeloid leukemia
Article Snippet: Cells were seeded at 10 3 cells/mL in a semi-solid methylcellulose medium (MethoCult H4230; StemCell Technologies Inc., Vancouver, Canada) supplemented with 10% FBS in 12-well plates.

Article Title: Mitochondrial DNA Mutations Determine Favourable Molecular Responses to Targeted Kinase Inhibitor Therapy and Impair Oxidative Phosphorylation
Article Snippet: After 3 days, cells from each condition were transferred in methylcellulose-based medium (MethoCult H4034 Optimum, STEMCELL Technologies) in duplicate and colonies were manually counted after 12-14 days.

Article Title: Modulating immune cell fate and inflammation through CRISPR-mediated DNA methylation editing
Article Snippet: Next, the cells were stained against the macrophage marker CD11b (1:200 of CD11b-APC, BD Pharmingen, catalog no. 550019) and CD14 (1:200 of CD14-APC, BD Pharmigen, catalog no. 561383) and resuspended in PBS containing DAPI as a viability marker.

Cell Culture:

Article Title: Lactate regulates cell differentiation of erythroid progenitor cells via histone lactylation modification
Article Snippet: .. Cultured cells were plated in triplicate at a density of 200 cells in 1 mL of MethoCult H4434 classic medium (Cat# 04434, STEMCELL) or in 1mL of MethoCult H4330 medium with EPO only (Cat# 04330, STEMCELL). ..



Similar Products

96
Miltenyi Biotec cd34 fraction
Cd34 Fraction, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd34++fraction/CD34+MicroBead+Kit+UltraPure%2C+human/bio_rxiv__64898__2025__12__22__695871-246-1-6
Average 96 stars, based on 1 article reviews
cd34 fraction - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

99
Miltenyi Biotec cd34 cell fractions
Cd34 Cell Fractions, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd34++fraction/CD34-VioBlue/us12203096-489-17-31
Average 99 stars, based on 1 article reviews
cd34 cell fractions - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

99
Miltenyi Biotec cd34 cell fraction
Cd34 Cell Fraction, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd34++fraction/CD34-VioBlue/pm39277669-53-1-17
Average 99 stars, based on 1 article reviews
cd34 cell fraction - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

99
Qiagen cd34 cell fraction
Cd34 Cell Fraction, supplied by Qiagen, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd34++fraction/miRNeasy+Micro+Kit/pmc11604037-358-7-18
Average 99 stars, based on 1 article reviews
cd34 cell fraction - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

90
Glaxo Smith autologous cd34+-enriched cell fraction strimvelis
FDA/EMA approved gene therapy product for rare monogenic diseases
Autologous Cd34+ Enriched Cell Fraction Strimvelis, supplied by Glaxo Smith, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd34++fraction/strimvelis/pmc11222908-222-7-8
Average 90 stars, based on 1 article reviews
autologous cd34+-enriched cell fraction strimvelis - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


FDA/EMA approved gene therapy product for rare monogenic diseases

Journal: Clinical and Experimental Pediatrics

Article Title: Development of orphan drugs for rare diseases

doi: 10.3345/cep.2023.00535

Figure Lengend Snippet: FDA/EMA approved gene therapy product for rare monogenic diseases

Article Snippet: For instance, an autologous CD34+-enriched cell fraction, Strimvelis (GlaxoSmithKline plk, London, UK), which contains CD34+ cells transduced with a retroviral vector that encodes the human ADA cDNA sequence for ADA deficiency (introduced in 2016), and voretigene neparvovec-rzyl (Luxturna, Spark Therapeutics, Philadelphia, USA), for retinal dystrophy caused by mutations in the RPE65 gene, were approved by the FDA in 2017 at a cost of $850,000 per eye [ ].

Techniques: Plasmid Preparation, In Vivo, Ex Vivo, Mutagenesis, Modification, Variant Assay